It is now known that CD8+ T cells out number CD4+ cells in the human MS plaques [1], [2] and undergo oligoclonal expansion at the site of pathology [3]–[5], indicating an important functional role at the site of pathology. Here, CD8A is linked to myeloid sarcoma.